Back to search
FDAFDA · Food and drugs·Recall number Z-0200-2015

Oxoid Legionella BCYE Growth Supplement SR0110A, packaged in 100 ml vials, 10/pkg. A growth supplement for the isolation of Legionella.

Published November 19, 2014 · Recall initiated: October 17, 2014

Summary

FDA records medical device Class II recall Z-0200-2015, published November 19, 2014 and initiated October 17, 2014. Recalling firm: Remel Inc; Status: Terminated; Reported quantity: 16/10/100 ml, vial, pkgs; Lot: Lot Number: 1451506 Expiration: 26Feb2016. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Recalled product may not provide adequate recovery of Legionella pneumophila when used as directed and may result in false negative identification of Legionella pneumophila.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Remel Inc
Distributor
Distributed in the states of ND, VT and TX.
Lot
Lot Number: 1451506 Expiration: 26Feb2016
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Oxoid Legionella BCYE Growth Supplement SR0110A, packaged in 100 ml vials, 10/pkg. A growth supplement for the isolation of Legionella. recalled?

Yes. FDA published recall Z-0200-2015 on November 19, 2014. Reported hazard: Recalled product may not provide adequate recovery of Legionella pneumophila when used as directed and may result in false negative identification of Legionella pneumophila.

What should I do if I have this product?

Voluntary: Firm initiated · Letter